Ridings P C, Sugerman H J, Blocher C R, Fisher B J, Fowler A A
Department of Surgery, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.
J Invest Surg. 1995 Mar-Apr;8(2):115-22. doi: 10.3109/08941939509016514.
Activation of the kallikrein-kinin system in sepsis has long been recognized, but its role, beneficial or pathologic, has not been defined. Recently, however, specific bradykinin (BK) antagonists have become available and this study investigated the effects of a BK antagonist, NPC17731 (Scios-Nova) on systemic and pulmonary hemodynamics in a model of gram-negative sepsis. Anesthetized swine were studied for 5 h receiving a 1-h infusion of saline (controls, group 1, N = 8) or live Pseudomonas aeruginosa (septic, group 2, N = 8). Group 3 (treatment, N = 6) received NPC17731 (5 mg/kg initial bolus followed by 1 mg/kg hourly) just prior to the onset of sepsis. Group 2 animals showed a rapid decrease in systemic arterial pressure (SAP) from 30 min onward, and sustained significant hypotension from 2 h onward. In group 3, SAP fell similarly until 2 h then progressively rose, returning to baseline levels by 5 h. In contrast, cardiac index fell progressively from 3 h onward in groups 2 and 3. Systemic vascular resistance index (SVRI) fell significantly by 2 h in group 2 animals, recovering to baseline by 5 h. Group 3 showed a similar initial fall followed by a rebound increase in SVRI, which, at 5 h was significantly raised above the other groups. Group 2 developed significant, persistent pulmonary artery hypertension which was not reduced by NPC17731. The data imply a significant role for bradykinin in the pathogenesis of hypotension in septic shock in this model. Septic shock was reversed by a BK antagonist which increased peripheral resistance without affecting cardiac output.(ABSTRACT TRUNCATED AT 250 WORDS)
长期以来,人们一直认识到脓毒症中激肽释放酶-激肽系统的激活,但其有益或病理作用尚未明确。然而,最近有了特异性缓激肽(BK)拮抗剂,本研究在革兰氏阴性脓毒症模型中研究了BK拮抗剂NPC17731(Scios-Nova)对全身和肺血流动力学的影响。对麻醉的猪进行5小时的研究,一组(对照组,第1组,N = 8)输注1小时生理盐水,另一组(脓毒症组,第2组,N = 8)输注活的铜绿假单胞菌。第3组(治疗组,N = 6)在脓毒症发作前接受NPC17731(初始推注5 mg/kg,随后每小时1 mg/kg)。第2组动物从30分钟起全身动脉压(SAP)迅速下降,从2小时起持续出现明显低血压。在第3组中,SAP同样下降至2小时,然后逐渐上升,到5小时恢复到基线水平。相比之下,第2组和第3组的心指数从3小时起逐渐下降。第2组动物的全身血管阻力指数(SVRI)在2小时时显著下降,到5小时恢复到基线。第3组显示出类似的初始下降,随后SVRI反弹增加,在5小时时显著高于其他组。第2组出现显著的持续性肺动脉高压,且未被NPC17731降低。数据表明缓激肽在该模型脓毒症休克低血压发病机制中起重要作用。BK拮抗剂可逆转脓毒症休克,增加外周阻力而不影响心输出量。(摘要截断于250字)